Literature DB >> 6797153

Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis.

K Yamamoto, D L Granger, W Brehmer, I Azuma, E Ribi.   

Abstract

Because the pulmonary granuloma formation by mycobacterial cell walls (CW) is likely mediated by cellular immunity, the effect of specific antigens and various immunosuppressants on pulmonary granuloma formation and protection against virulent m. tuberculosis, strain H37Rv was investigated in mice immunized with oil-treated CW from BCG or M. Tuberculosis, strain Aoyama B. Results of desensitization experiments with specific antigens showed that multiple intravenous injections of BCG protoplasm inhibited the footpad delayed hypersensitivity, macrophage migration inhibitory activity of lung cells and pulmonary granuloma formation as well as the enhancement of resistance against aerosol challenge with M, tuberculosis, strain H37Rv. However, treatment with nonspecific immunosuppressants like con A, silica or carrageenan induced only abrogation of footpad delayed hypersensitivity but not prevention of pulmonary granuloma formation or resistance against aerosol challenge. These results suggest a close relationship between pulmonary granuloma formation and protection against H37Rv in mice immunized with oil-treated mycobacterial CW.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6797153

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0174-3031


  2 in total

1.  Microbicidal activity and morphological characteristics of lung macrophages in Mycobacterium bovis BCG cell wall-induced lung granuloma in mice.

Authors:  K Kato; K Yamamoto; H Okuyama; T Kimura
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

2.  Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials.

Authors:  E Ribi; D L Granger; K C Milner; K Yamamoto; S M Strain; R Parker; R W Smith; W Brehmer; I Azuma
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.